NCT00608543View on ClinicalTrials.gov

Aripiprazole Augmentation of SSRI Therapy in Treatment Refractory Depression

PHASE4CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

January 31, 2009

Study Completion Date

January 31, 2009

Conditions
Major Depressive Disorder
Interventions
DRUG

Aripiprazole

varied dose (5, 10, 15 mg qd) for 6 wks

Trial Locations (1)

752390-9119

University of Texas Southwestern Medical Center at Dallas, Dallas

Sponsors

Collaborators (1)

Bristol-Myers Squibb
All Listed Sponsors
collaborator

Bristol-Myers Squibb

INDUSTRY

lead

University of Texas Southwestern Medical Center

OTHER